Physicians' perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic

被引:9
|
作者
Auanassova, Akerke [1 ]
Yessirkepov, Marlen [1 ]
Zimba, Olena [2 ]
Gasparyan, Armen Yuri [3 ,4 ]
Joshi, Mrudula [5 ,6 ]
Agarwal, Vikas [7 ]
Kitas, George D. [3 ,4 ,8 ]
Ahmed, Sakir [7 ,9 ]
机构
[1] South Kazakhstan Med Acad, Dept Biol & Biochem, Shymkent, Kazakhstan
[2] Danylo Halytsky Lviv Natl Med Univ, Dept Internal Med 2, Lvov, Ukraine
[3] Univ Birmingham, Dudley Grp NHS Fdn Trust, Teaching Trust, Dept Rheumatol,Russells Hall Hosp, Dudley, W Midlands, England
[4] Univ Birmingham, Dudley Grp NHS Fdn Trust, Teaching Trust, Dept Res & Dev,Russells Hall Hosp, Dudley, W Midlands, England
[5] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India
[6] Sassoon Gen Hosp, Pune, Maharashtra, India
[7] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
[8] Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England
[9] KIIT Univ, Kalinga Inst Med Sci KIMS, Dept Clin Immunol & Rheumatol, Bhubaneswar 751024, India
关键词
Anti-neutrophilic cytoplasmic antibodies; Cardiovascular risks; COVID-19; Eosinophilic GPA; Granulomatosis with polyangiitis; Microscopic granulomatosis; ANCA-ASSOCIATED VASCULITIS;
D O I
10.1007/s10067-022-06452-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects. They present with a myriad of systemic features and require potent immunosuppression. Since they are uncommonly encountered in clinical practice, it is necessary to understand physicians' knowledge and perceptions about this group of diseases. An online questionnaire was designed featuring 28 questions based on relevant global practice guidelines, recommendations, and previous online surveys on AAV. The questionnaire was validated by a core group of specialists with an interest in AAV. It was shared via social networking sites and entries were restricted to physicians. Only completed entries were analyzed with descriptive statistics. A total of 113 respondents from 21 different countries responded of whom the commonest were rheumatologists, internists, and general practitioners. Forty-five (40%) ran clinics dedicated to AAV patients as a part of their practice. They commented on organs involved in AAV; vasculitis secondary to infections, drugs or other rheumatic diseases; various tests useful for AAV diagnosis; and drug choices for induction and maintenance. They mentioned their experience regarding COVID-19 in AAV patients as well as vasculitic manifestations of COVID-19. Various methods to mitigate cardiovascular risks in AAV were mentioned. Finally, the respondents indicated how medical education needed to be strengthened to increase awareness and knowledge regarding AAV. This survey helped to inform about various perceptions regarding AAV across countries, including current practices and recent evolution of management. It also provided information on treatment of the COVID-19 in AAV patients. This survey showed that there is still a lack in understanding the prevalent definitions and there is gap between guidelines and current practice.
引用
收藏
页码:831 / 837
页数:7
相关论文
共 50 条
  • [1] Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
    Akerke Auanassova
    Marlen Yessirkepov
    Olena Zimba
    Armen Yuri Gasparyan
    Mrudula Joshi
    Vikas Agarwal
    George D. Kitas
    Sakir Ahmed
    Clinical Rheumatology, 2023, 42 : 831 - 837
  • [2] Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech
    Suzuki, Minami
    Sekiguchi, Yuta
    Sasaki, Masato
    Inaba, Shunsuke
    Oyama, Sakino
    Inoue, Yuichi
    Warabi, Masahiro
    Ohashi, Kenichi
    Inoshita, Seiji
    INTERNAL MEDICINE, 2022, 61 (19) : 2925 - 2929
  • [3] New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination
    Yang, Yang
    Xiong, Yi
    Xu, Gaosi
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 213 (03) : 301 - 309
  • [4] Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination
    Okuda, Saki
    Hirooka, Yasuaki
    Sugiyama, Masafumi
    VACCINES, 2021, 9 (08)
  • [5] Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with COVID-19: A Single Center Experience
    Latief, Muzamil
    Mir, Tajamul H.
    Wani, Mohd L.
    INDIAN JOURNAL OF NEPHROLOGY, 2023, 33 (01) : 50 - 53
  • [6] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
    Rich, Eric N.
    Brown, Kevin K.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 447 - 454
  • [7] Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Keller, Sarah F.
    Miloslavsky, Eli M.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 91 - +
  • [8] Antineutrophil cytoplasmic antibody-associated vasculitis
    Konda, Raghunandan
    Rajasekaran, Arun
    Rizk, Dana V.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (05) : 503 - 511
  • [9] Possible Association Between COVID-19 Infection and De Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Madanchi, Nima
    Stingo, Facundo E.
    Patrick, Kennerly C.
    Muthusamy, Selvaraj
    Gupta, Neha
    Fatani, Yahya Imran
    Shah, Nehal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [10] Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zonozi, Reza
    Niles, John L.
    Cortazar, Frank B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 525 - +